Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
1. The effects of immunoglobulin G (IgG) from patients with Lambert-Eaton myasthenic syndrome on Ca2+ currents in mammalian motor nerve terminals are unknown. Therefore, we recorded these currents in phrenic nerves of mice injected with serum from either LEMS patients, myasthenia gravis patients, or healthy control individuals. 2. In control preparations, the endplate currents induced by repetitive stimulation at > or = 20 Hz were depressed as expected. However, in the LEMS animals quantal content decreased and either depression did not occur or synaptic facilitation occurred. 3. Ca2+ currents were smaller in LEMS animals. At 0.5 Hz stimulation frequency, normalized Ca2+ currents in LEMS animals were 57 +/- 14% of those in control. At higher frequencies, Ca2+ currents become smaller in control but not in LEMS animals. 4. Ca2+ currents in controls were unaffected by addition of nifedipine but were reduced by 37% upon addition of omega-conotoxin GVIA. In LEMS animals, however, the currents were depressed by 43% by nifedipine but were unaffected by omega-conotoxin GVIA. Thus, LEMS is associated with reduced Ca2+ currents and a shift to dihydropyridine sensitivity.
D000818:Animals; D001790:Blood Physiological Phenomena; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004553:Electric Conductivity; D004558:Electric Stimulation; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000097:blood / Q000503:physiopathology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009045:Motor Endplate / Q000502:physiology; D009132:Muscles / Q000294:innervation*; D009157:Myasthenia Gravis / Q000097:blood; D009411:Nerve Endings / Q000187:drug effects / Q000502:physiology*; D010791:Phrenic Nerve / Q000503:physiopathology; D012016:Reference Values
D002121:Calcium Channel Blockers; D002118:Calcium